Xenon Pharmaceuticals - Articles and news items

Teva and Xenon provide update on TV-45070 Phase 2b study in osteoarthritis pain

Industry news / 1 July 2015 / Victoria White

Teva and Xenon have reported top line results from a Phase 2b study designed to evaluate the safety and efficacy of TV-45070 in patients with osteoarthritis…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+